再鼎医药（09688）今日盘中股价大跌18.23%，引发市场广泛关注。这一显著跌幅似乎与公司最新公布的股权激励计划有关。
根据再鼎医药发布的公告，公司计划向40名承授人授出可认购合共20.47万股美国存托股份的购股权，向381名承授人授出涉及合共42.01万股美国存托股份的受限制股份单位，并向4名承授人授出涉及合共3.3万股美国存托股份的业绩股份单位。这一大规模的股权激励计划涉及总计425名员工，可能引发了投资者对股权稀释的担忧。
分析人士指出，虽然股权激励计划旨在吸引和留住人才，有利于公司的长期发展，但短期内可能会对股价造成压力。投资者可能担心这种大规模的股权授予会稀释现有股东的权益，从而导致股价下跌。市场将密切关注再鼎医药未来的业务表现，以评估这一股权激励计划的长期影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
No relevant data is available